BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38239047)

  • 21. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
    Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
    Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.
    Mosley M; Knight J; Neesse A; Michl P; Iezzi M; Kersemans V; Cornelissen B
    J Nucl Med; 2015 May; 56(5):745-51. PubMed ID: 25840973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hafnium-doped hydroxyapatite nanoparticles with ionizing radiation for lung cancer treatment.
    Chen MH; Hanagata N; Ikoma T; Huang JY; Li KY; Lin CP; Lin FH
    Acta Biomater; 2016 Jun; 37():165-73. PubMed ID: 27060620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
    Yu M; Chen Y; Wang Z; Ding X
    Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.
    Richert MM; Phadke PA; Matters G; DiGirolamo DJ; Washington S; Demers LM; Bond JS; Manni A; Welch DR
    Breast Cancer Res; 2005; 7(5):R819-27. PubMed ID: 16168128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
    Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
    Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer.
    Li C; Yoshimura T; Tian M; Wang Y; Kondo T; Yamamoto KI; Fujisawa M; Ohara T; Sakaguchi M; Matsukawa A
    Breast Cancer Res; 2022 Sep; 24(1):60. PubMed ID: 36096830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Cellular and Microenvironmental Multidrug Resistance on Tumor-Targeted Drug Delivery in Triple-Negative Breast cancer.
    Tezcan O; Elshafei AS; Benderski K; Rama E; Wagner M; Moeckel D; Pola R; Pechar M; Etrych T; von Stillfried S; Kiessling F; Weiskirchen R; Meurer S; Lammers T
    J Control Release; 2023 Feb; 354():784-793. PubMed ID: 36599395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation.
    Sasaki SI; Zhang D; Iwabuchi S; Tanabe Y; Hashimoto S; Yamauchi A; Hayashi K; Tsuchiya H; Hayakawa Y; Baba T; Mukaida N
    Cancer Sci; 2021 Dec; 112(12):4883-4893. PubMed ID: 34632664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of PET Imaging for Prognostic Integrin α
    Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
    Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model.
    Rahman A; Janic B; Rahman T; Singh H; Ali H; Rattan R; Kazi M; Ali MM
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894298
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
    Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic and heterotopic triple negative breast cancer preclinical murine models: A tumor microenvironment comparative.
    Santana-Krímskaya SE; Kawas JR; Zarate-Triviño DG; Ramos-Zayas Y; Rodríguez-Padilla C; Franco-Molina MA
    Res Vet Sci; 2022 Dec; 152():364-371. PubMed ID: 36108549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness.
    Shah L; Latif A; Williams KJ; Tirella A
    Acta Biomater; 2022 Oct; 152():273-289. PubMed ID: 36087866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer.
    Pavuluri K; Yang E; Ayyappan V; Sonkar K; Tan Z; Tressler CM; Bo S; Bibic A; Glunde K; McMahon MT
    Theranostics; 2022; 12(4):1937-1951. PubMed ID: 35198081
    [No Abstract]   [Full Text] [Related]  

  • 39. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
    Capozza M; Anemone A; Dhakan C; Della Peruta M; Bracesco M; Zullino S; Villano D; Terreno E; Longo DL; Aime S
    Mol Imaging Biol; 2022 Feb; 24(1):126-134. PubMed ID: 34383241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model.
    Shirke AA; Wang J; Ramamurthy G; Mahanty A; Walker E; Zhang L; Panigrahi A; Wang X; Basilion JP
    Mol Imaging Biol; 2024 May; ():. PubMed ID: 38760621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.